APA (7th ed.) Citation

Kubasch, A. S., Schulze, F., Giagounidis, A., Götze, K. S., Krönke, J., Sockel, K., . . . Platzbecker, U. (2020). Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents. Leukemia, 34(4), . https://doi.org/10.1038/s41375-019-0645-z

Chicago Style (17th ed.) Citation

Kubasch, Anne Sophie, et al. "Single Agent Talacotuzumab Demonstrates Limited Efficacy but Considerable Toxicity in Elderly High-risk MDS or AML Patients Failing Hypomethylating Agents." Leukemia 34, no. 4 (2020). https://doi.org/10.1038/s41375-019-0645-z.

MLA (9th ed.) Citation

Kubasch, Anne Sophie, et al. "Single Agent Talacotuzumab Demonstrates Limited Efficacy but Considerable Toxicity in Elderly High-risk MDS or AML Patients Failing Hypomethylating Agents." Leukemia, vol. 34, no. 4, 2020, https://doi.org/10.1038/s41375-019-0645-z.